Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir

BACKGROUND: In this study, we aimed to compare the intensive care unit (ICU) admission rate of hospitalized mild/moderate COVID-19 patients treated with hydroxychloroquine (HCQ), favipiravir, and HCQ plus favipiravir. METHODS: Single center retrospective designed observational study conducted in Ank...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Infect Public Health
Egile Nagusiak: Guner, Rahmet, Hasanoglu, Imran, Kayaaslan, Bircan, Aypak, Adalet, Akinci, Esragul, Bodur, Hurrem, Eser, Fatma, Kaya Kalem, Ayse, Kucuksahin, Orhan, Ates, Ihsan, Bastug, Aliye, Tezer Tekce, Yasemin, Bilgic, Zeynep, Gursoy, Fahriye Melis, Akca, Hatice Nisa, Izdes, Seval, Erdem, Deniz, Asfuroglu, Emra, Hezer, Habibe, Kilic, Hatice, Cıvak, Musa, Aydogan, Sibel, Buzgan, Turan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7771901/
https://ncbi.nlm.nih.gov/pubmed/33647553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2020.12.017
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak